Article(id=1326653016461128578, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326653015873926017, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.01.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1730649600000, receivedDateStr=2024-11-04, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228327144, onlineDateStr=2026-11-09, pubDate=1736438400000, pubDateStr=2025-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228327144, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228327144, creator=13701087609, updateTime=1794228327144, updator=13701087609, issue=Issue{id=1326653015873926017, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='1', pageStart='1', pageEnd='103', issueExtLink='null', onlineDate='null', pubDate='1736438400000', pubDateStr='2025-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228327004, creator='13701087609', updateTime=1794273113022, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840862513935350, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326653015873926017, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840862513935351, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326653015873926017, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1, endPage=7, ext={EN=ArticleExt(id=1326653016721175428, articleId=1326653016461128578, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Application of new biological agents in the treatment of immune-related kidney diseases, columnId=null, journalTitle=World Clinical Drug, columnName=null, runingTitle=null, highlight=null, articleAbstract=
The development of novel biologics provides a new therapeutic strategy for immune-related kidney diseases. Novel biologics such as anti-leukocyte differentiation antigen 20 monoclonal antibody, B lymphocyte stimulator/a proliferation-inducing ligand-targeting drugs, and complement inhibitors provide more precise treatment for immune-related kidney diseases by targeting specific molecules or receptors. However, further studies are needed in terms of therapeutic efficacy, safety, optimal dosage and applicability in different kidney diseases. This article reviewed the application progress of various novel biologics in immune-related kidney diseases, and aimed to discuss their therapeutic potential, existing evidence and future research direction.
, authors=Sainan ZHANG
1, Niansong WANG
2, *, Wei ZHANG
1, *, authorsList=Sainan ZHANG, Niansong WANG, Wei ZHANG, authorCompany=null, correspAuthors=Niansong WANG, Wei ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326653016964445061, articleId=1326653016461128578, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=新型生物制剂在免疫相关性肾病中的应用, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=
新型生物制剂的开发为免疫相关性肾病提供了新的治疗策略。抗白细胞分化抗原20单抗、B淋巴细胞刺激因子/增殖诱导配体靶向药物以及补体抑制剂等新型生物制剂通过靶向特定的分子或受体,为免疫介导的肾脏疾病提供更精准的治疗手段,但在治疗有效性、安全性、最佳剂量及在不同肾脏疾病中的适用性等方面尚待进一步研究。该文综述各类新型生物制剂在免疫相关性肾病中的应用进展,旨在探讨其治疗潜力、现有证据及未来研究方向。
, authors=张赛男
1, 汪年松
2, *, 张玮
1, *, authorsList=张赛男, 汪年松, 张玮, authorCompany=null, correspAuthors=汪年松, 张玮, authorNote=
, correspAuthorsNote=
汪年松,主任医师,教授,博士生导师,研究方向:糖尿病肾病、急性肾损伤发病机制和防治
张玮,主治医师,研究方向:中医内科。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=YUwh+8td3Fvsn1a5PBGfig==, magXml=iaj63JteokMKRt78EyFWNQ==, pdfUrl=null, pdf=XtJAEEpfMFm0PEKFSVIzZA==, pdfFileSize=1315077, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=avqHChf2zbyaSjRIjN704g==, mapNumber=null, fund=null)}, authors=[Author(id=1326653017572619149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326653017643922319, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, authorId=1326653017572619149, language=EN, stringName=Sainan ZHANG, firstName=Sainan, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326653017711031184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, authorId=1326653017572619149, language=CN, stringName=张赛男, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.上海市杨浦区中医医院肾病科,上海 200090, bio={"content":"
张赛男,主治医师,研究方向:慢性肾脏病诊疗。
"}, bioImg=null, bioContent=
张赛男,主治医师,研究方向:慢性肾脏病诊疗。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326653017388069766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, xref=1., ext=[AuthorCompanyExt(id=1326653017413235591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017388069766, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1326653017421624200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017388069766, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.上海市杨浦区中医医院肾病科,上海 200090)])]), Author(id=1326653017769751442, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326653017832666004, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, authorId=1326653017769751442, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326653017887191957, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, authorId=1326653017769751442, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.上海交通大学医学院附属第六人民医院肾脏内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326653017488733065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, xref=2., ext=[AuthorCompanyExt(id=1326653017501315978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017488733065, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200233, China), AuthorCompanyExt(id=1326653017509704587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017488733065, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海交通大学医学院附属第六人民医院肾脏内科,上海 200233)])]), Author(id=1326653017945912215, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326653018021409689, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, authorId=1326653017945912215, language=EN, stringName=Wei ZHANG, firstName=Wei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326653018113684378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, authorId=1326653017945912215, language=CN, stringName=张玮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.上海市杨浦区中医医院肾病科,上海 200090, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326653017388069766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, xref=1., ext=[AuthorCompanyExt(id=1326653017413235591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017388069766, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1326653017421624200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017388069766, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.上海市杨浦区中医医院肾病科,上海 200090)])])], keywords=[Keyword(id=1326653018243707803, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=EN, orderNo=1, keyword=biological agent), Keyword(id=1326653018302428060, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=EN, orderNo=2, keyword=immune-related kidney disease), Keyword(id=1326653018377925533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=EN, orderNo=3, keyword=anti-leukocyte differentiation antigen 20 monoclonal antibody), Keyword(id=1326653020198253470, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=EN, orderNo=4, keyword=B lymphocyte stimulator/a proliferation-inducing ligand-targeting drug), Keyword(id=1326653020374414240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=EN, orderNo=5, keyword=complement inhibitor), Keyword(id=1326653020454106017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=CN, orderNo=1, keyword=生物制剂), Keyword(id=1326653020554769314, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=CN, orderNo=2, keyword=免疫相关性肾病), Keyword(id=1326653020747707299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=CN, orderNo=3, keyword=抗白细胞分化抗原20单抗), Keyword(id=1326653020848370596, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=CN, orderNo=4, keyword=B细胞刺激因子/增殖诱导配体靶向药物), Keyword(id=1326653021188109221, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, language=CN, orderNo=5, keyword=补体抑制剂)], refs=[Reference(id=1326653022177964970, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=LASSEN E, DAEHN IS. Insights into glomerular function and disease pathogenesis[J]. Nat Rev Nephrol, 2023, 19(2):85-86., articleTitle=null, refAbstract=null), Reference(id=1326653022299599787, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=BASU B, ANGELETTI A, ISLAM B,
et al. New and old anti-CD20 monoclonal antibodies for nephrotic syndrome.where we are?[J]. Front Immunol, 2022, 13: 805697., articleTitle=null, refAbstract=null), Reference(id=1326653022458983340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会肾脏病学分会专家组. 利妥昔单抗在肾小球肾炎中应用的专家共识[J]. 中华肾脏病杂志, 2022, 38(2):151-160., articleTitle=null, refAbstract=null), Reference(id=1326653022664504237, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=RUDNICKI M. Rituximab for treatment of membranoproliferative glomerulonephritis and C3 glomerulopathies[J]. Biomed Res Int, 2017, 2017: 2180508., articleTitle=null, refAbstract=null), Reference(id=1326653022849053614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=JONES RB, TERVAERT JW, HAUSER T,
et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis[J]. N Engl J Med, 2010, 363(3): 211-220., articleTitle=null, refAbstract=null), Reference(id=1326653024606466991, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=STONE JH, MERKEL PA, SPIERA R,
et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis[J].N Engl J Med, 2010, 363(3): 221-232., articleTitle=null, refAbstract=null), Reference(id=1326653024744879024, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CORTAZAR FB, MUHSIN SA, PENDERGRAFT WF 3rd,
et al. Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis[J]. Kidney Int Rep, 2017, 3(2): 394-402., articleTitle=null, refAbstract=null), Reference(id=1326653024900068273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=WALLACE ZS, FU X, COOK C,
et al. Comparative effectiveness of rituximab- versus cyclophosphamide-based remission induction strategies in antineutrophil cytoplasmic antibody-associated vasculitis for the risk of kidney failure and mortality[J]. Arthritis Rheumatol, 2023, 75(9): 1599-1607., articleTitle=null, refAbstract=null), Reference(id=1326653025013314482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=SCOLARI F, DELBARBA E, SANTORO D,
et al. Rituximab or cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO randomized trial[J]. J Am Soc Nephrol, 2021, 32(4): 972-982., articleTitle=null, refAbstract=null), Reference(id=1326653025248195507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FERVENZA FC, APPEL GB, BARBOUR SJ,
et al.Rituximab or cyclosporine in the treatment of membranous nephropathy[J]. N Engl J Med, 2019, 381(1): 36-46., articleTitle=null, refAbstract=null), Reference(id=1326653025344664500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=HANSET N, ESTEVE E, PLAISIER E,
et al. Rituximab in patients with phospholipase A2 receptor-associated membranous nephropathy and severe CKD[J]. Kidney Int Rep, 2020, 5(3): 331-338., articleTitle=null, refAbstract=null), Reference(id=1326653025445327797, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=HARTINGER JM, KRATKY V, HRUSKOVA Z,
et al. Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives[J]. Front Immunol, 2022, 13: 1024068., articleTitle=null, refAbstract=null), Reference(id=1326653025558574006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=MESCIA F, SALVIANI C, TONOLI M,
et al. Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal function[J].Nephrol Dial Transplant, 2024, 39(4): 683-693., articleTitle=null, refAbstract=null), Reference(id=1326653025642460087, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=TEISSEYRE M, CREMONI M, BOYER-SUAVET S,
et al. Advances in the management of primary membranous nephropathy and rituximab-refractory membranous nephropathy[J]. Front Immunol, 2022, 13: 859419., articleTitle=null, refAbstract=null), Reference(id=1326653025730540472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=HAUSER SL, KAPPOS L, BAR-OR A,
et al. The development of ofatumumab, a fully human anti-CD20 monoclonal antibody for practical use in relapsing multiple sclerosis treatment[J]. Neurol Ther, 2023, 12(5): 1491-1515., articleTitle=null, refAbstract=null), Reference(id=1326653025793455033, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG CS, LIVERMAN RS, GARRO R,
et al. Ofatumumab for the treatment of childhood nephrotic syndrome[J]. Pediatr Nephrol, 2017, 32(5): 835-841., articleTitle=null, refAbstract=null), Reference(id=1326653025885729722, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=HAARHAUS ML, SVENUNGSSON E, GUNNARSSON I.Ofatumumab treatment in lupus nephritis patients[J]. Clin Kidney J, 2016, 9(4): 552-555., articleTitle=null, refAbstract=null), Reference(id=1326653025978004411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=REYNOLDS BC, LAMB A, JONES CA,
et al. UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant[J]. Pediatr Nephrol, 2022, 37(1): 199-207., articleTitle=null, refAbstract=null), Reference(id=1326653026070279100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=LUNDBERG S, WESTERGREN E, SMOLANDER J,
et al. B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis[J]. Clin Kidney J, 2017, 10(1): 20-26., articleTitle=null, refAbstract=null), Reference(id=1326653026187719613, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=PODESTA MA, TRILLINI M, PORTALUPI V,
et al.Ofatumumab in rituximab-resistant and rituximab-intolerant patients with primary membranous nephropathy: a case series[J]. Am J Kidney Dis, 2024, 83(3): 340-349., articleTitle=null, refAbstract=null), Reference(id=1326653026548429758, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=RAVANI P, COLUCCI M, BRUSCHI M,
et al. Human or chimeric monoclonal anti-CD20 antibodies for children with nephrotic syndrome: a superiority randomized trial[J]. J Am Soc Nephrol, 2021, 32(10): 2652-2663., articleTitle=null, refAbstract=null), Reference(id=1326653026753950655, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=MYSLER EF, SPINDLER AJ, GUZMAN R,
et al. Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase Ⅲstudy[J]. Arthritis Rheum, 2013, 65(9): 2368-2379., articleTitle=null, refAbstract=null), Reference(id=1326653026867196864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=FREEMAN CL, SEHN LH. A tale of two antibodies:obinutuzumab versus rituximab[J]. Br J Haematol, 2018,182(1): 29-45., articleTitle=null, refAbstract=null), Reference(id=1326653027097883585, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=ROVIN BH, FURIE RA, ROSS TERRES JA,
et al.Kidney outcomes and preservation of kidney function with obinutuzumab in patients with lupus nephritis: a post hoc analysis of the NOBILITY trial[J]. Arthritis Rheumatol,2024, 76(2): 247-254., articleTitle=null, refAbstract=null), Reference(id=1326653027211129795, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=SETHI S, KUMAR S, LIM K,
et al. Obinutuzumab is effective for the treatment of refractory membranous nephropathy[J]. Kidney Int Rep, 2020, 5(9): 1515-1518., articleTitle=null, refAbstract=null), Reference(id=1326653027328570308, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=CAI J, GAO D, LIU D,
et al. Telitacicept for autoimmune nephropathy[J]. Front Immunol, 2023, 14: 1169084., articleTitle=null, refAbstract=null), Reference(id=1326653028993708997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=YU X, CHEN N, XUE J,
et al. Efficacy and safety of belimumab in patients with lupus nephritis: subgroup analyses of a phase 3 randomized trial in the east asian population[J].Am J Kidney Dis, 2023, 81(3): 294-306., articleTitle=null, refAbstract=null), Reference(id=1326653029077595078, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Kidney Disease: Improving Global Outcomes(KDIGO)Lupus Nephritis Work Group. KDIGO 2024 clinical practice guideline for the management of LUPUS NEPHRITIS[J].Kidney Int, 2024, 105(1S): S1-S69., articleTitle=null, refAbstract=null), Reference(id=1326653029182452679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=DHILLON S. Telitacicept: first approval[J]. Drugs, 2021,81(14): 1671-1675., articleTitle=null, refAbstract=null), Reference(id=1326653029337641928, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=JIN HZ, LI YJ, WANG X,
et al. Efficacy and safety of telitacicept in patients with systemic lupus erythematosus:a multicentre, retrospective, real-world study[J]. Lupus Sci Med, 2023, 10(2): e001074., articleTitle=null, refAbstract=null), Reference(id=1326653029413139401, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=LV J, LIU L, HAO C,
et al. Randomized phase 2 trial of telitacicept in patients with IgA nephropathy with persistent proteinuria[J]. Kidney Int Rep, 2023, 8(3): 499-506., articleTitle=null, refAbstract=null), Reference(id=1326653029497025482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=GORDON C, BASSI R, CHANG P,
et al. Integrated safety profile of atacicept: an analysis of pooled data from the atacicept clinical trial programme[J]. Rheumatol Adv Pract,2019, 3(2): rkz021., articleTitle=null, refAbstract=null), Reference(id=1326653029576717259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=BARRATT J, TUMLIN J, SUZUKI Y,
et al. Randomized phaseⅡ JANUS study of atacicept in patients with IgA nephropathy and persistent proteinuria[J]. Kidney Int Rep,2022, 7(8): 1831-1841., articleTitle=null, refAbstract=null), Reference(id=1326653029660603340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=LAFAYETTE R, BARBOUR S, ISRANI R,
et al. A phase 2b,randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy[J]. Kidney Int,2024, 105(6): 1306-1315., articleTitle=null, refAbstract=null), Reference(id=1326653029723517901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=WOODEN B, TARRAGON B, NAVARRO-TORRES M,
et al. Complement inhibitors for kidney disease[J]. Nephrol Dial Transplant, 2023, 38(Supplement_2): ii29-ii39., articleTitle=null, refAbstract=null), Reference(id=1326653029782238158, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=FAKHOURI F, HOURMANT M, CAMPISTOL JM,
et al.Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial[J]. Am J Kidney Dis, 2016, 68(1): 84-93., articleTitle=null, refAbstract=null), Reference(id=1326653029845152719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=LE QUINTREC M, LAPEYRAQUE A L, LIONET A,
et al.Patterns of clinical response to eculizumab in patients with C3 glomerulopathy[J]. Am J Kidney Dis, 2018, 72(1): 84-92., articleTitle=null, refAbstract=null), Reference(id=1326653029903872976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=JAYNE DRW, MERKEL PA, SCHALL TJ,
et al. Avacopan for the treatment of ANCA-associated vasculitis[J]. N Engl J Med, 2021, 384(7): 599-609., articleTitle=null, refAbstract=null), Reference(id=1326653029958398929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=CORTAZAR FB, NILES JL, JAYNE DRW,
et al. Renal recovery for patients with ANCA-associated vasculitis and low eGFR in the ADVOCATE trial of avacopan[J]. Kidney Int Rep, 2023, 8(4): 860-870., articleTitle=null, refAbstract=null), Reference(id=1326653030021313490, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=ZOTTA F, DIOMEDI-CAMASSEI F, GARGIULO A,
et al.Successful treatment with avacopan(CCX168) in a pediatric patient with C3 glomerulonephritis[J]. Pediatr Nephrol,2023, 38(12): 4197-4201., articleTitle=null, refAbstract=null), Reference(id=1326653030121976787, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=PERKOVIC V, KOLLINS D, PAPACHRISTOFI O,
et al.Efficacy and safety of iptacopan in patients with primary IgA nephropathy: interim analysis results of the Phase 3 APPLAUSE-IgAN study[J]. Nephrol Dial Transpl, 2024,39(Supplement_1): S506., articleTitle=null, refAbstract=null), Reference(id=1326653030180697044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=FURIE R, NICHOLLS K, CHENG TT,
et al. Efficacy and safety of abatacept in lupus nephritis: a twelve-month,randomized, double-blind study[J]. Arthritis Rheumatol,2014, 66(2): 379-389., articleTitle=null, refAbstract=null), Reference(id=1326653030247805909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=JOY MS, GIPSON DS, POWELL L,
et al. Phase 1 trial of adalimumab in focal segmental glomerulosclerosis(FSGS):Ⅱ. Report of the FONT(novel therapies for resistant FSGS)study group[J]. Am J Kidney Dis, 2010, 55(1): 50-60., articleTitle=null, refAbstract=null), Reference(id=1326653030306526166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=PLANT R, RAFI AHMED A, MCHALE T,
et al. A case of adalimumab-induced granulomatous interstitial nephritis[J].Cureus, 2021, 13(6): e15986., articleTitle=null, refAbstract=null), Reference(id=1326653030382023639, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=BHAGAT SINGH AK, JEYARUBAN AS, WILSON GJ,
et al. Adalimumab-induced IgA nephropathy[J]. Bio Med J Case Rep, 2019, 12(3): e226442., articleTitle=null, refAbstract=null), Reference(id=1326653030465909720, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=JAYNE D, ROVIN B, MYSLER E,
et al. Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase Ⅱ trial[J]. Lupus Sci Med, 2023, 10(2):e000910., articleTitle=null, refAbstract=null), Reference(id=1326653030533018585, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=KALE A, LECH M, ANDERS HJ,
et al. Lupus nephritis: new and emerging biologic and targeted therapies[J]. BioDrugs,2023, 37(4): 463-475., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326653021435573158, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, awardId=82270761, language=CN, fundingSource=国家自然基金面上项目(82270761), fundOrder=null, country=null), Fund(id=1326653021666259879, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, awardId=2023YFC2411803, language=CN, fundingSource=国家重点研发计划(2023YFC2411803), fundOrder=null, country=null), Fund(id=1326653021783700393, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, awardId=2022ZZ01002(3), language=CN, fundingSource=上海市重中之重研究中心建设项目(2022ZZ01002(3)), fundOrder=null, country=null), Fund(id=1326653021855003561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, awardId=ZY(2021-2023)-0205-04, language=CN, fundingSource=上海市进一步加快中医药传承创新发展三年行动计划(ZY(2021-2023)-0205-04), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326653017388069766, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, xref=1., ext=[AuthorCompanyExt(id=1326653017413235591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017388069766, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1326653017421624200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017388069766, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.上海市杨浦区中医医院肾病科,上海 200090)]), AuthorCompany(id=1326653017488733065, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, xref=2., ext=[AuthorCompanyExt(id=1326653017501315978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017488733065, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200233, China), AuthorCompanyExt(id=1326653017509704587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326653016461128578, companyId=1326653017488733065, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.上海交通大学医学院附属第六人民医院肾脏内科,上海 200233)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.01.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.01.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.01.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.01.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1736438400000, fullTextJson=null, articleText=null, reference=null)